The Effect of Alendronate and Intranasal Calcitonin Treatments on Bone Mineral Density in Men with Idiopathic Osteoporosis

The aim of this study was to compare the effect of alendronate and calcitonin treatments on bone mineral density (BMD) in men with idiopathic osteoporosis. After performing a detailed clinical and laboratory assessment in order to eliminate secondary factors that can lead to osteoporosis, fifty-two...

Full description

Bibliographic Details
Published in:	Türk Osteoporoz Dergisi
Main Authors:	F. Taşçıoğlu, Ayşe Aydemir, C. Öner
Format:	Article
Language:	English
Published:	Turkish Society of Osteoporosis 2003-03-01
Subjects:	Alendronate calcitonin idiopathic male osteoporosis
Online Access:	http://www.turkosteoporozdergisi.org/article_4080/The-Effect-Of-Alendronate-And-Intranasal-Calcitonin-Treatments-Onbone-Mineral-Density-In-Men-With-Idiopathic-Osteoporosis

Similar Items

The Comparison of Effects of Alendronate and Calcitonin Treatment in Men With Osteoporosis
by: Gülcan Gürer, et al.
Published: (2004-09-01)

The Effect of Alendronate and Calcitonin Treatments on Bone Mineral Density and Quality of Life in Women With Postmenopausal Osteoporosis
by: F. Taşçıoğlu, et al.
Published: (2002-06-01)

Two Years of Alendronate and Calcitonin Treatments for Osteoporosis in Postmenopausal Women - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01)

Effects of Alendronate, Calcitonin and Raloxifene Used in the Treatment of Postmenopausal Osteoporosis On Serum No Levels
by: Saliha Karatay, et al.
Published: (2005-03-01)

The Effect of Alendronate in Male Osteoporosis
by: Özlem El, et al.
Published: (2004-12-01)

The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis
by: İlker Çorapçı, et al.
Published: (2004-03-01)

The Effect of Continous or Intermittent Calcitonin in the Treatment of Postmenopausal Osteoporosis
by: F. Taşçıoğlu, et al.
Published: (2002-03-01)

Use of alendronate in the therapy of osteoporosis
by: O. B. Ershova
Published: (2020-01-01)

Effect of Vitamin K and Alendronate Combination Treatment on Bone Mineral Density of Postmenopausal Osteoporosis Patients: A Pilot Study
by: Mohammad Hassan Jokar, et al.
Published: (2016-01-01)

Efficacy of generic alendronate and ibandronate in post menopausal osteoporosis
by: NP Somasundaram, et al.
Published: (2012-03-01)

Evaluation of Alendronate Efficacy on Bone Mineral Density in Thalassemic Patients
by: Fatemeh Shirani, et al.
Published: (2012-10-01)

Evaluation of Alendronate Efficacy on Bone Mineral Density in Thalassemic Patients
by: Fatemeh Shirani, et al.
Published: (2015-10-01)

The comparison of effects of alendronate and raloxifene treatment in postmenauposal women with osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2005-12-01)

An academic clinical study to assess the efficacy and safety of nandrolone decanoate and alendronate compared with alendronate alone in patients with osteoporosis
by: Bharat R Dave, et al.
Published: (2023-01-01)

The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01)

Bone-targeted polymeric nanoparticles as alendronate carriers for potential osteoporosis treatment
by: Chunlan Jing, et al.
Published: (2022-06-01)

Efficacy and safety of alendronic acid in the treatment of osteoporosis in children
by: Alberto Martín Siguero, et al.
Published: (2015-11-01)

Effect of Weekly Alendronate on Knee Symptoms in Patients with Osteoporosis and Knee Osteoarthritis Coexistence - Original Investigation
by: Levent Ediz, et al.
Published: (2010-04-01)

REVIEW OF BASIC CLINICAL TRIALS OF ALENDRONATE
by: E G Zotkin, et al.
Published: (2010-03-01)

Efficacy and Safety of Generic Alendronate for Osteoporosis Treatment
by: Jarusriwanna A, et al.
Published: (2024-02-01)

Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
by: Kurtuluş Kaya, et al.
Published: (2009-12-01)

Irrational use of alendronate sodium by the elderly
by: Camila Pereira Alvim, et al.
Published: (2020-11-01)

Atypical femoral fracture in the setting of alendronate treatment for osteoporosis: a case report and literature review
by: Eric D. Van Baarsel, et al.
Published: (2019-07-01)

Alendronate-associated Polyarticular Synovitis: A Case Report
by: Büşra Şirin, et al.
Published: (2024-04-01)

Circular RNA atlas in osteoclast differentiation with and without alendronate treatment
by: Jianbiao Lin, et al.
Published: (2020-07-01)

The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis
by: S. Akı, et al.
Published: (2002-03-01)

Rheumatoid arthritis, osteoporosis, possibilities for the correction of bone mineral density
by: Rimma Mikhailovna Balabanova
Published: (2012-09-01)

The Efficacy of Nasal Calcitonin on The Treatment of Osteoporosis in Male Patients with Ankylosing Spondylitis: A Preliminary Study - Original Investigation
by: Pınar Borman, et al.
Published: (2007-09-01)

The Efficacy of Alendronate Treatment in Ambulatory Stroke Patients
by: Nihal ÖZARAS, et al.
Published: (2016-04-01)

Experience with Alendronate Treatment for Four Years among Japanese Men with Osteoporosis or Osteopenia and Clinical Risk Factors for Fractures [Retraction]
by: Iwamoto J, et al.
Published: (2022-08-01)

Chitosan/Nanohydroxyapatite/Hydroxyethyl-cellulose-based printable formulations for local alendronate drug delivery in osteoporosis treatment
by: Simindokht Afra, et al.
Published: (2024-06-01)

Comparison of the Efficacy of Daily and Weekly Oral Alendronate Treatment in Patients with Secondary Osteoporosis
by: Sezer Acar, et al.
Published: (2019-12-01)

The Effects of Once-Weekly Alendronate 70 mg, Risedronate 35 mg and Raloxifene 60 mg Daily in the Treatment of Postmenopausal Osteoporosis in Turkish Population
by: Mesut Öktem, et al.
Published: (2007-04-01)

Facile fabrication of phosphazene-quercetin-alendronate composites as pH-responsive bone-targeted nanomedicine for osteoporosis treatment
by: Xiaowei Yang, et al.
Published: (2024-05-01)

Cardioprotective effects of alendronate bisphosphonate in patients with ischemic heart disease associated with type 2 diabetes mellitus and osteoporosis
by: S. N. Shilov, et al.
Published: (2021-05-01)

The efficacy of alendronate for the treatment of thalassemia-associated osteoporosis: a randomized controlled trial
by: Pokpong Piriyakhuntorn, et al.
Published: (2023-05-01)

Alendronate Functionalized Bone-Targeting Pomolic Acid Liposomes Restore Bone Homeostasis for Osteoporosis Treatment
by: Xia D, et al.
Published: (2024-08-01)

Evaluation of bone remodelling parameters after one year treatment with alendronate in postmenopausal women with osteoporosis
by: Elma Kučukalić-Selimović, et al.
Published: (2011-02-01)

OSTEOPOROSIS: A VIEW OF THE PROBLEM OF DIAGNOSIS AND TREATMENT
by: Nataliya Vladimirovna Toroptsova
Published: (2009-09-01)

Fabrication, assessment, and optimization of alendronate sodium nanoemulsion-based injectable in-situ gel formulation for management of osteoporosis
by: Wesam H. Abdulaal, et al.
Published: (2023-12-01)